DelveInsight’s Excessive Daytime Sleepiness (EDS) Market Insights Report offers a detailed analysis of Disease, its causes, symptoms, diagnostics modalities, and treatment options.
Excessive Daytime Sleepiness market size, epidemiology, innovative therapies, market drivers, market barriers, ongoing clinical trials, critical collaboration in the room, and key pharmaceutical companies actively moving the market size forward are all covered in-depth in the study.
Some of the key highlights from the Excessive Daytime Sleepiness Market Insights:
Learn more by requesting for sample @ Excessive Daytime Sleepiness (EDS) Market Landscape
Excessive Daytime Sleepiness (EDS): Overview
Excessive Daytime Sleepiness is characterized by a struggle to remain awake and alert throughout the day’s main waking episodes, with sleep occurring accidentally or at inopportune times.
EDS is linked to various illnesses, including metabolic, cardiovascular, neurological, and psychological disorders, as well as voluntary habits that signify inadequate sleep and sleep debt, which can lead to impairment and increased mortality risk. EDS is often linked to social and economic implications, making it a severe public health problem.
For more insights into Excessive Daytime Sleepiness, causes, and treatment, reach out to Excessive Daytime Sleepiness (EDS) Treatment Landscape.
Excessive Daytime Sleepiness Epidemiology Segmentation
The Excessive Daytime Sleepiness Market report proffers epidemiological analysis for the study period 2017-30 in the 7MM segmented into:
Visit for more @ Excessive Daytime Sleepiness Epidemiological Insights
Excessive Daytime Sleepiness Market
As per DelveInsight, in 2017, the market of EDS was USD 2,587.4 million in the 7MM. The primary need of EDS was estimated by different approved treatments such as Wakix (Pitolisant) and Xyrem (sodium oxybate), Sunosi, etc.
The market is expected to grow by factors like an increase in the patient pool due to a rise in the prevalence of underlying medical conditions, desired entry of emerging therapies, i.e., such as FT218 (Sodium Oxybate) Extended-Release Oral Suspension, JZP-258, BEN-2001, THN102, Wakix (Pitolisant): for OSA, and AXS-12 (Reboxetine), and deeper penetration in the 7MM markets.
Excessive Daytime Sleepiness Pipeline Therapies and Key Companies
For more information, visit Excessive Daytime Sleepiness Market Analysis, Patient Pool, and Emerging Therapies.
Excessive Daytime Sleepiness Market Drivers
Scope of the Report
Key Questions Answered in the Report
Get in touch with our Business executive @ Excessive Daytime Sleepiness Market Landscape Analysis.
Table of Contents:
1. | Key Insights |
2. | Report Introduction |
3. | Competitive Intelligence Analysis for Excessive Daytime Sleepiness |
4. | Excessive Daytime Sleepiness Market Overview at a Glance |
5. | Executive Summary of Excessive Daytime Sleepiness |
6. | Excessive Daytime Sleepiness Epidemiology and Market Methodology |
7. | Excessive Daytime Sleepiness Epidemiology and Patient Population |
8. | Excessive Daytime Sleepiness Patient Journey |
9. | Treatment Algorithm, Current Treatment, and Medical Practices |
10. | Critical Endpoints in Excessive Daytime Sleepiness Clinical Trials |
11. | Excessive Daytime Sleepiness Marketed Therapies |
12. | Excessive Daytime Sleepiness Emerging Therapies |
13. | Excessive Daytime Sleepiness: 7 Major Market Analysis |
14. | Attribute analysis |
15. | Access and Reimbursement Overview of Excessive Daytime Sleepiness |
16. | KOL Reviews |
17. | Case Reports |
18. | Excessive Daytime Sleepiness Market Drivers |
19. | Excessive Daytime Sleepiness Market Barriers |
20. | SWOT Analysis |
21. | Disclaimer |
22. | DelveInsight Capabilities |
23. | About DelveInsight |
Learn more about the report offerings @ Excessive Daytime Sleepiness (EDS) Market Outlook
Related Reports
Obstructive Sleep Apnea Market
DelveInsight’s “Obstructive Sleep Apnea Market Insights, Epidemiology, and Market Forecast – 2030” Report.
Obstructive Sleep Apnea Pipeline
DelveInsight’s “Obstructive Sleep Apnea (OSA) Pipeline Insights, 2021” Report.
Obstructive Sleep Apnea (OSA) Epidemiology
DelveInsight’s “Obstructive Sleep Apnea (OSA) – Epidemiology Forecast to 2030” Report.
DelveInsight’s “Restless Leg Syndrome – Market Insights, Epidemiology, and Market Forecast-2030” Report.
Restless Legs Syndrome Pipeline
DelveInsight’s “Restless Legs Syndrome Pipeline Insights, 2021” Report.
Restless Leg Syndrome Epidemiology
DelveInsight’s “Restless Leg Syndrome – Epidemiology Forecast to 2030” Report.
DelveInsight’s “Narcolepsy–Market Insights, Epidemiology, and Market Forecast-2030” Report.
DelveInsight’s “Narcolepsy Pipeline Insights, 2021” Report.
DelveInsight’s “Narcolepsy – Epidemiology Forecast to 2030” Report.
DelveInsight’s “Insomnia – Market Insights, Epidemiology, and Market Forecast-2030” Report.
DelveInsight’s “Insomnia Pipeline Insights, 2021” Report.
DelveInsight’s “Insomnia – Epidemiology Forecast to 2030” Report.
DelveInsight’s “Chronic Insomnia—Market Insights, Epidemiology, and Market Forecast—2030” Report.
DelveInsight’s “Chronic Insomnia – Epidemiology Forecast—2030” Report.
DelveInsight’s “Sleep Apnea – Market Insights, Epidemiology, and Market Forecast-2030” Report.
DelveInsight’s “Sleep Apnea Pipeline Insights, 2021” Report.
DelveInsight’s “‘Sleep Apnea – Epidemiology Forecast to 2030” Report.
Related Blog:
Sleep Disorders: An Emerging Public Health Issue
Get in touch with our Business executive for Pharma and Healthcare
Market Assessment and Consulting
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences providing comprehensive end-to-end solutions to improve performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.